MedTrace Logo

Salvage Cryotherapy in Recurrent Prostate Cancer

NCT00824928 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-05-27

No results posted yet for this study

Summary

To provide a systemic, uniform and user-friendly tool for collection of data on prostate cancer salvage cryotherapy in a multicenter setting. The goal is to learn more about the short and long term efficacy and safety of this procedure. Ultimately the data analysis will serve as a robust guidance instrument for improving upon the utilization of this procedure for the treatment of patients with recurrent (LRD) prostate cancer.

Conditions

  • Recurrent Prostate Cancer

Interventions

PROCEDURE

Cryoablation / Cryotherapy

Salvage Cryoablation of the prostate

Sponsors & Collaborators

  • Boston Scientific Corporation

    collaborator INDUSTRY

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Al Barqawi, MD · University of Colorado, Denver

  • David Crawford, MD · University of Colorado, Denver

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-06-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00824928 on ClinicalTrials.gov